Sweden· SE-20240625000014
Embesin 40 IE/2 ml Koncentrat till infusionsvätska, lösning
A medicinal product containing argipressin, registered in Sweden by Orifarm AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Argipressin
- Manufacturer
- Orifarm AB
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20240625000014
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Argipressin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandEmpressinOrpha-Devel Handels und Vertriebs GmbH
- BelgiumReverpleg 40 IU/2 mlOrpha-Devel Handels und Vertriebs
- IrelandEmbesin 20 IU/ml concentrate for solution for infusionOrpha-Devel Handels und Vertriebs GmbH
- NorwayEmpressinOrpha-Devel Handels und Vertriebs GmbH
- PolandEmpesinOrpha-Devel Handels und Vertriebs GmbH
- United StatesvasopressinAmneal Pharmaceuticals LLC
- United KingdomArgipressin 20units/1ml solution for injection ampoulesAOP Orphan Ltd
- SwitzerlandEmpressin, Konzentrat zur Herstellung einer InfusionslösungOrPha Swiss GmbH
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Empesin
- Belgium · Reverpleg
- Bulgaria · Емпресин
- Czechia · Embesin
- Germany · Argipressin Farmak, Empressin
- Denmark · Empressin
- Estonia · Empesin
- Spain · Empressin
- Finland · Empressin
- France · Reverpleg
- United Kingdom (Northern Ireland) · Argipressin Aop, Argipressin Mercury Pharmaceuticals
- Greece · Empressin
- Croatia · Empressin
- Hungary · Embesyn
- Ireland · Embesin
- Italy · Empressin
- Lithuania · Empesin
- Luxembourg · Reverpleg
- Latvia · Empesin
- Netherlands · Empressine
- Norway · Empressin
- Poland · Argipressin Farmak, Empesin
- Portugal · Empressin
- Romania · Reverpleg
- Slovenia · Empesin
- Slovakia · Embesin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/14b88f08-a5ac-4161-bea9-526325ddb98d GET /v1/drugs/14b88f08-a5ac-4161-bea9-526325ddb98d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"PL"
],
"se_npl_id": "20240625000014",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20240625000014",
"product_doc_link": "https://docetp.mpa.se/LMF/Embesin%2040%20IU%20per%202%20ml%20concentrate%20for%20solution%20for%20infusion%20SK%20PL_09001bee845a4cb4.pdf"
}See everything about argipressin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.